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Glioblastoma multiforme (GBM) is the most common 
malignant brain tumor in adults. The current standard of care 
includes surgery followed by radiotherapy (RT) and 
chemotherapy with temozolomide (TMZ). Treatment often 
fails due to the radiation and TMZ resistance of a small 
percentage of cells with stem cell-like behavior (CSC). The 
Notch signaling pathway is expressed and active in human 
glioblastoma and Notch inhibitors attenuate tumor growth in 
vivo in xenograft models. Here I will discuss the results of 
studies investigating combination treatments of RT 
Temozolomide and NOTCH inhibitors in an orthotopic model 
of Glioblastoma. Small Animal image guided preciscion 
Radiotherapy (SmART) treatment planning and delivery was 
used to achieve highly accurate dose prescriptions and 
treatment monitoring. Studies will be presented that 
investigate the role for NOTCH signaling in treatment 
response in different 2D and 3D culture systems. 
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Figure Legend: SmART image-guided treatment plan for 
orthotopic GBM model. PTV (red), normal brain (blue) and 
parallel irradiation beams (green) 
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Stroma mediated wound healing signals induced by 
radiotherapy have been well characterized in normal tissue 
response and fibrosis. They are complex and involve the 
crosstalk between the various cellular type of the tissue 
including fibroblasts, endothelial, immune, epithelial cells as 
well as soluble paracrine factors including growth factors and 
proteases. In addition, recent studies suggest that these 
wound healing signals may share similarities with the ones 
produced by tumor’s microenvironment. Therefore, their 
modulation may impact both normal tissue and tumor 
response to radiation therapy. 
This lecture will illustrate the two important aspects of 
stroma mediated wound healing signals in normal tissue and 
tumour response to radiotherapy.   
In a recent study (1), we investigated the role of 
macrophages in radiation-induced lung fibrosis, profiled 
alveolar (AM) and interstitial macrophages (IM) and show that 
both macrophage subtypes are playing specific and opposite 
role in fibrogenesis. Acute depletion of AM post-irradiation 
was shown and associated with cytokine secretion. This acute 
depletion was followed by a repopulation mediated via the 
recruitment and proliferation of monocytes/macrophages 
from the bone marrow. Interestingly, the newly recruited 
Alveolar macropahages exhibited hybrid polarization 
(M1/M2), associated with the up-regulation of both Th1 and 
Th2 cytokines. At delayed times points post-irradiation, 
interstitial macrophages were M2 polarized and 
simultaneously, a down-regulation of Th1 cytokines and up-
regulation of Th2 cytokines was observed in irradiated lungs. 
The specific depletion of hybrid AM enhanced the severity of 
fibrosis whereas anti-fibrotic treatment based upon 
pravastatin administration decreased M2-IM levels.  We also 
found that M2-IM were able to activate fibroblast into 
myofibroblasts when co-cultured.   
In another study (2), we assessed the crosstalk between 
primary lung fibroblast and carcinoma cells (TC-1) in 
response to radiotherapy. We found that fibroblasts were not 
able to modulate intrinsic radiosensitivity of TC-1 but 
produce diffusible factors able to modify tumor cell fate. 
More specifically, RhoB deficient fibroblasts stimulated TC-1 
migration through MMPs production whereas WT fibroblasts 
produce TGF-.  In addition RhoB deficiency stimulated pro-
inflammatory signals (IL-6) that would impact on immune 
recruitment and favor antitumor immune response. In 
addition, co-irradiation of fibroblasts and TC-1 abrogated the 
pro-migratory phenotype by repression of TGF-β and MMP 
secretion. This last result suggests that conversely to, the 
current view; irradiated stroma would not enhance 
